BioGaia AB (publ)
BIOG-B
Rang in Aktien
#7842
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
Aktienkurs
$13.86
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$1.37B
Veränderung (1 Tag)
0.65%
Veränderung (1 Jahr)
23.21%
Land
SE
Handel BioGaia AB (publ) (BIOG-B)
Kategorie
Healthcare
Marktkapitalisierung von BioGaia AB (publ)(BIOG-B)
Marktkapitalisierung: $1.37B
Mit Stand October 2026 hat BioGaia AB (publ) eine Marktkapitalisierung von $1.37B. Das macht BioGaia AB (publ) laut unseren Daten zum 7842nd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von BioGaia AB (publ) von 2015 bis 2026
BIOG-B im Vergleich zu den Top 5 der beliebtesten stocks
